πŸ‡ΊπŸ‡Έ Karmanos Now Offers FDA-Approved Daraxonrasib (Rasonque) for Metastatic Pancreatic Cancer

πŸ‡ΊπŸ‡Έ

Karmanos participated in the pivotal international RASolute 302 clinical trial supporting FDA approval DETROIT, Aug. 31, 2026 /PRNewswire/ — The Barbara Ann Karmanos Cancer Institute is now offering a new treatment for pancreatic cancer that will soon change how advanced disease is…

Source: prnewswire

Country: United States